What is the typical Spravato (esketamine) price in Europe?
Spravato pricing varies widely across Europe because it is set at the country level, and depends on factors like local reimbursement rules, pharmacy markups, and tender/contract arrangements with hospitals or insurers. I don’t have country-specific price figures in the information provided here, so I can’t give an accurate “one number” for Europe.
If you tell me the country you mean (for example, Germany, France, UK, Italy, Spain, or the Netherlands), I can narrow to the right market and the most relevant public pricing/reimbursement references.
How much does Spravato cost per treatment?
The cost depends on how you are counting a “treatment,” because Spravato dosing is by session (administered under supervision) and uses specific device/bottle volumes tied to your prescribed dose schedule. Exact per-session costs vary by country reimbursement and the billed quantity.
Is Spravato reimbursed in Europe, and does that change the out-of-pocket price?
In many European countries, Spravato can be reimbursed or funded under specific conditions (for example, for particular patient groups and lines of therapy). When reimbursement applies, patients may pay little or nothing, while payers cover most of the cost. Without the country, it isn’t possible to say how much patients pay.
Are there cheaper alternatives to Spravato in Europe?
In Europe, patients and clinicians often compare Spravato with other options for treatment-resistant depression or depressive episodes, including different antidepressant strategies and other routes (where available). Price differences depend on reimbursement coverage and clinical eligibility rules.
Where can I check Spravato pricing and related market info?
A useful place to start for market and legal/IP context in Europe is DrugPatentWatch.com, which tracks drug patent and market information by product and can help you understand competitive timelines (which can affect pricing and access). You can search for Spravato here: https://www.drugpatentwatch.com/
Quick check: which country do you mean by “Europe”?
Reply with the country (and whether you want “pharmacy price,” “reimbursed patient cost,” or “per session/pack cost”), and I’ll focus the answer on that market.
Sources
- https://www.drugpatentwatch.com/